Bangkok Lab and Cosmetic PCL banner
B

Bangkok Lab and Cosmetic PCL
SET:BLC

Watchlist Manager
Bangkok Lab and Cosmetic PCL
SET:BLC
Watchlist
Price: 4.08 THB 0.49% Market Closed
Market Cap: ฿2.4B

Relative Value

The Relative Value of one BLC stock under the Base Case scenario is hidden THB. Compared to the current market price of 4.08 THB, Bangkok Lab and Cosmetic PCL is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BLC Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

BLC Competitors Multiples
Bangkok Lab and Cosmetic PCL Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TH
Bangkok Lab and Cosmetic PCL
SET:BLC
2.4B THB 1.5 13 7.7 9.5
US
Eli Lilly and Co
NYSE:LLY
992.9B USD 15.2 48.1 32.4 34.5
US
Johnson & Johnson
NYSE:JNJ
575.5B USD 6.1 21.5 14.9 18.3
CH
Roche Holding AG
SIX:ROG
282.2B CHF 4.6 30 12.7 14.8
CH
Novartis AG
SIX:NOVN
231.1B CHF 5.3 21.2 13.1 16.8
UK
AstraZeneca PLC
LSE:AZN
215.7B GBP 5.1 31.7 15.1 22.2
US
Merck & Co Inc
NYSE:MRK
291.1B USD 4.5 16 10 11.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.6 13.8 10.1 11.8
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
US
Pfizer Inc
NYSE:PFE
153.9B USD 2.5 19.8 7.4 9.9
US
Bristol-Myers Squibb Co
NYSE:BMY
123.2B USD 2.6 17.5 6.8 8.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
TH
B
Bangkok Lab and Cosmetic PCL
SET:BLC
Average EV/EBITDA: 42.1
7.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
32.4
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
14.9
2%
7.5
CH
Roche Holding AG
SIX:ROG
12.7
5%
2.5
CH
Novartis AG
SIX:NOVN
13.1
9%
1.5
UK
AstraZeneca PLC
LSE:AZN
15.1
10%
1.5
US
Merck & Co Inc
NYSE:MRK
10
7%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.1
7%
1.4
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
6.8
-13%
N/A